Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the cartilage volume loss at the Baseline visit
and after 24 months of treatment in patients treated with CHONDROITIN SULPHATE (CONDROSAN)
1200 mg daily vs. patients treated with CELECOXIB 200 mg daily.